<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02980783</url>
  </required_header>
  <id_info>
    <org_study_id>GMA-EAME-FAS-0397</org_study_id>
    <nct_id>NCT02980783</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Dynamic Radial Cheek Line Skin Depressions</brief_title>
  <acronym>BEAM</acronym>
  <official_title>BEAM: Prospective Open Label Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Treatment of Dynamic Radial Cheek Line Skin Depressions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effectiveness of Juvéderm® VOLIFT®™ with Lidocaine for dynamic
      radial cheek line skin depressions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 3, 2016</start_date>
  <completion_date type="Actual">December 14, 2016</completion_date>
  <primary_completion_date type="Actual">December 14, 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subject Rating of Their Improvement of Dynamic Radial Cheek Lines on the 5-Point Global Aesthetic Improvement Scale (GAIS)</measure>
    <time_frame>Day 0, Day 45</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Day 0 in Mean Roughness (Ra) of Radial Cheek Lines at Maximum Smile</measure>
    <time_frame>Day 0, Day 45</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Day 0 in Mean Amplitude (Rt) of Radial Cheek Lines at Maximum Smile</measure>
    <time_frame>Day 0, Day 45</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Day 0 in Mean Texture (Rz) of Radial Cheek Lines at Maximum Smile</measure>
    <time_frame>Day 0, Day 45</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Day 0 in Wrinkle Volume of Radial Cheek Lines at Maximum Smile</measure>
    <time_frame>Day 0, Day 45</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator Rating of Dynamic Radial Cheek Lines on the 5-Point GAIS</measure>
    <time_frame>Day 0, Day 45</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Change from Day 0 in Self-Perception of Age (SPA)</measure>
    <time_frame>Day 0, Day 45</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Assessment of Natural Look of Their Treated Dynamic Radial Cheek Lines on a Patient Reported Questionnaire</measure>
    <time_frame>Day 45</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Cheek Line Depressions</condition>
  <arm_group>
    <arm_group_label>Juvéderm® VOLIFT®™ with Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Juvéderm® VOLIFT®™ with Lidocaine is injected into the dynamic radial cheek line skin depressions on Day 0; volume of injection will not exceed 2mL per side. If applicable, a touch-up of Juvéderm® VOLIFT®™ with Lidocaine will be injected on Day 14; volume will not exceed 1mL per side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Juvéderm® VOLIFT®™ with Lidocaine</intervention_name>
    <description>Juvéderm® VOLIFT®™ with Lidocaine is injected into the dynamic radial cheek line skin depressions on Day 0; volume of injection will not exceed 2mL per side. If applicable, a touch-up of Juvéderm® VOLIFT®™ with Lidocaine will be injected on Day 14; volume will not exceed 1mL per side.</description>
    <arm_group_label>Juvéderm® VOLIFT®™ with Lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of dynamic radial cheek lines

          -  Agrees not to make any changes to skin care routines, or to have any facial procedures
             or treatments during the study

        Exclusion Criteria:

          -  Previous facial surgery, tissue grafting, or tissue augmentation with silicone, fat,
             or other permanent, or semi-permanent dermal fillers or be planning to undergo any of
             these procedures during the study

          -  Undergone temporary facial dermal filler injections with any substance in the face in
             the 12 months prior to study entry

          -  Received botulinum toxin therapy of any serotype in any facial area within the
             previous 6 months agrees not to receive it during the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graeme Kerson</last_name>
    <role>Study Director</role>
    <affiliation>Allergan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratoire DERMSCAN</name>
      <address>
        <city>Lyon</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.allerganclinicaltrials.com</url>
    <description>More Information</description>
  </link>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2016</study_first_submitted>
  <study_first_submitted_qc>November 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2016</study_first_posted>
  <last_update_submitted>July 20, 2017</last_update_submitted>
  <last_update_submitted_qc>July 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>January 8, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

